로그인 회원가입 일정관리 전체메뉴
로그인 회원가입

산학협력단 로고

우수성과 정보광장

SOONCHUNHYANG INDUSTRY-ACADEMY COOPERATION FOUNDATION

홈아이콘
정보광장
우수성과

공유아이콘 공유아이콘 프린트아이콘

우수성과

총 373 건 (7/38페이지)
번호 논문명 학술지구분 학술지명 IF 저자명
313 [25년 4월] Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer’s Disease and Parkinson’s Disease SCIE International Journal of Nanomedicine 6.7 정영현
312 [25년 4월] Therapeutic effects of CGS21680, a selective A2A receptor agonist, via BDNF-related pathways in R106W mutation Rett syndrome model SCIE Biomedicine & Pharmacotherapy 6.9 김진
311 [25년 3월] Mitigating anodic corrosion in aluminum–air batteries: Effects of alkalimetal cation size on electrochemical performance SCIE APPLIED SURFACE SCIENCE 6.3 정순기
310 [25년 3월] The implications of bioelectrical impedance vector analysis in older adults with hip fractures SCIE Maturitas 3.9 임승규
309 [25년 3월] Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study SCIE Nature Communications 14.7 장윤우
308 [25년 3월] Mono-ubiquitination of TopBP1 by PHRF1 enhances ATR activation and genomic stability SCIE NUCLEIC ACIDS RESEARCH 16.7 김우태
307 [25년 3월] Effect of daily temperature variations on years of life lost from suicide in the capital city of South Korea SSCI Journal of Psychiatric Research 3.7 이혜원, 정수빈
306 [25년 3월] Real-time marketing messages and consumer engagement in social media SSCI Journal of Business Research 10.5 채명진
305 [25년 2월] The Dual Dimensions of Virtual Reality Gaming: An Empirical Study on Enjoyment and Cybersickness SCIE HUMAN-CENTRIC COMPUTING AND INFORMATION SCIENCES 3.9 권혁준
304 [25년 2월] Inhaled corticosteroid increased the risk of adrenal insufficiency in patients with chronic airway diseases: a nationwide population-based study SCIE Scientific Reports 3.8 이혜원, 윤희영
검색
인사말 주요통계 자회사현황 찾아오시는길
자주묻는 질문/답변 입주기업지원 조직도/업무분장

순천향대학교 산학협력단 / 충남 아산시 순천향로 22 앙뜨레프레너관 / TEL. 041-530- 4894((표준현장실습), 4857(캡스톤디자인), 1442(특허및기술이전), 1609(연구기획), 1103(연구비관리)/ FAX. 041-530-1083
COPYRIGHT (C) SCH ALL RIGHTS RESERVED.